Nolan Sean P. is Chief Executive Officer of Taysha Gene Therapies Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Ventas, Inc.
16 May 24
4
Taysha Gene Therapies, Inc.
4 Jan 24
4
Taysha Gene Therapies, Inc.
18 Dec 23
4
Taysha Gene Therapies, Inc.
16 Aug 23
4
Ventas, Inc.
18 May 23
4
Taysha Gene Therapies, Inc.
4 Jan 23
4
Taysha Gene Therapies, Inc.
22 Jun 22
4
Ventas, Inc.
29 Apr 22
3
Social Capital Suvretta Holdings Corp. II
24 Sep 21
4
Taysha Gene Therapies, Inc.
21 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 May 24 | VTR Ventas | Common Stock | Grant | Acquire A | No | No | 47.96 | 3,648 | 174.96 k | 21,252 |
2 Jan 24 | TSHA Taysha Gene Therapies | Common Stock | Grant | Acquire A | No | No | 0 | 1,184,688 | 0.00 | 1,185,858 |
2 Jan 24 | TSHA Taysha Gene Therapies | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.71 | 1,184,688 | 2.03 mm | 1,184,688 |
14 Dec 23 | TSHA Taysha Gene Therapies | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.6989 | 466,550 | 326.07 k | 466,550 |
16 Aug 23 | TSHA Taysha Gene Therapies | Common Stock | Buy | Acquire P | Yes | No | 0.9 | 444,444 | 400.00 k | 1,535,545 |
16 May 23 | VTR Ventas | Common Stock | Grant | Acquire A | No | No | 45.63 | 3,835 | 174.99 k | 17,604 |